News Stories

Preventive VT Ablation Before ICD Helps High-risk Ischemic Cardiomyopathy Patients

EHRA 2024: Performing ventricular tachycardia (VT) ablation before placement of a primary prevention implantable cardioverter-defibrillator (ICD) had a clinical benefit in a selected group of ischemic cardiomyopathy patients at high risk for ventricular arrhythmias, results from the randomized PREVENTIVE VT trial show.

EHRA 2024: Closed loop stimulation rate-adaptive pacing may delay sub-clinical AF in sinus node disease

Clinical findings of the B3 study, assessing the impact of closed loop stimulation on the incidence of sub-clinical atrial fibrillation (AF) in sinus node disease patients, have been presented during a late-breaking trial session at the European Heart Rhythm Association (EHRA) 2024 congress (7–9 April, Berlin, Germany).

Biotronik introduces “first” complete system for LBBAP

Following the recent CE approval of the Solia S lead for left bundle branch area pacing (LBBAP), Biotronik has announced the first complete conduction system pacing (CSP) system, now fully CE-approved for LBBAP.

ICD Benefits Hold Up for Modern-day Primary Prevention, but Questions Remain

While device therapy appeared helpful on top of today’s HF therapies, not all patients were maxed out on four-pillar GDMT.

Micra Leadless Pacemaker Performs Well Through 5 Years

A real-world registry saw few complications and revisions, with no device removals due to infection, which is “a huge finding.”